Preservation of Reproductive Function Before Therapy for Cancer: New Options Involving Sperm and Ovary Cryopreservation
Overview
Authors
Affiliations
In summary, sperm cryopreservation for future ICSI and ovarian tissue cryopreservation for future autotransplantation are new opportunities to preserve reproductive options of great importance to patients with newly diagnosed cancer. Since patients must utilize these strategies before cancer therapy is initiated, and these patients will not have a future chance to benefit once therapy has damaged gonadal function, awareness of these technologies among oncologists, radiation therapists, and other colleagues who interface with the victims of cancer is a high priority.
Fertility-preserving treatment options in patients with malignant hematological diseases.
Kucuk M, Bolaman A, Yavasoglu I, Kadikoylu G Turk J Haematol. 2014; 29(3):207-16.
PMID: 24744663 PMC: 3986744. DOI: 10.5505/tjh.2012.72681.
Reinecke J, Kelvin J, Arvey S, Quinn G, Levine J, Beck L J Oncol Pract. 2013; 8(5):303-8.
PMID: 23277768 PMC: 3439231. DOI: 10.1200/JOP.2011.000452.
Fertility preservation in young cancer patients.
Revel A, Revel-Vilk S J Hum Reprod Sci. 2010; 3(1):2-7.
PMID: 20607000 PMC: 2890901. DOI: 10.4103/0974-1208.63113.
Ginsberg J, Carlson C, Lin K, Hobbie W, Wigo E, Wu X Hum Reprod. 2009; 25(1):37-41.
PMID: 19861330 PMC: 2794668. DOI: 10.1093/humrep/dep371.